We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
-0.01%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$35.6B
AUM Growth
+$1.38B
Cap. Flow
+$1.82B
Cap. Flow %
5.13%
Top 10 Hldgs %
28.03%
Holding
2,407
New
40
Increased
606
Reduced
1,352
Closed
406

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$172M
2
HON icon
Honeywell
HON
+$160M
3
MSFT icon
Microsoft
MSFT
+$159M
4
AMZN icon
Amazon
AMZN
+$91M
5
TSLA icon
Tesla
TSLA
+$89.8M

Sector Composition

Rank Sector Weight
1 Technology 27.11%
2 Consumer Discretionary 14.43%
3 Communication Services 10.72%
4 Healthcare 9.96%
5 Financials 9.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SFL icon
1901
SFL Corp
SFL
$1.59B
$112K ﹤0.01%
13,398
-13,727
-51% -$104K
DBD
1902
DELISTED
Diebold Nixdorf Incorporated
DBD
$112K ﹤0.01%
11,097
-9,699
-47% -$106K
VVNT
1903
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
$111K ﹤0.01%
11,744
-12,027
-51% -$144K
CGEN icon
1904
Compugen
CGEN
$216M
$107K ﹤0.01%
17,933
+2,898
+19% +$19.4K
CNSL
1905
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$107K ﹤0.01%
11,614
-9,702
-46% -$86.4K
SURF
1906
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$107K ﹤0.01%
14,171
-2,265
-14% -$14.5K
GOEV
1907
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$105K ﹤0.01%
30
-15
-33% -$53.5K
IDEX
1908
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$105K ﹤0.01%
425
-423
-50% -$123K
DFTX
1909
Definium Therapeutics
DFTX
$5.73B
$104K ﹤0.01%
2,973
-2,597
-47% -$112K
TXMD icon
1910
TherapeuticsMD
TXMD
$23.8M
$104K ﹤0.01%
2,810
-480
-15% -$21.3K
ATNX
1911
DELISTED
Athenex, Inc. Common Stock
ATNX
$104K ﹤0.01%
1,722
-240
-12% -$17.5K
ACCO icon
1912
Acco Brands
ACCO
$369M
$103K ﹤0.01%
11,945
-12,235
-51% -$108K
TCRR
1913
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$103K ﹤0.01%
12,076
-2,695
-18% -$38.1K
FLXN
1914
DELISTED
Flexion Therapeutics, Inc.
FLXN
$103K ﹤0.01%
16,916
-4,549
-21% -$28.4K
BRSP
1915
BrightSpire Capital
BRSP
$681M
$102K ﹤0.01%
10,822
-11,082
-51% -$107K
NEX
1916
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$102K ﹤0.01%
22,169
-22,706
-51% -$91.3K
PRTY
1917
DELISTED
Party City Holdco Inc.
PRTY
$101K ﹤0.01%
14,164
-14,510
-51% -$110K
CMO
1918
DELISTED
Capstead Mortgage Corp.
CMO
$99K ﹤0.01%
14,724
-12,654
-46% -$82.9K
NGNE icon
1919
Neurogene
NGNE
$696M
$98K ﹤0.01%
679
-158
-19% -$24.2K
RIDE
1920
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
$98K ﹤0.01%
821
-1,119
-58% -$116K
SYRS
1921
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$92K ﹤0.01%
2,061
-544
-21% -$26.6K
MGI
1922
DELISTED
MoneyGram International, Inc. New
MGI
$92K ﹤0.01%
11,476
-8,753
-43% -$83.4K
SLCA
1923
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$91K ﹤0.01%
11,343
-9,735
-46% -$92.1K
BDTX icon
1924
Black Diamond Therapeutics
BDTX
$101M
$90K ﹤0.01%
10,655
-1,751
-14% -$17.3K
PBYI icon
1925
Puma Biotechnology
PBYI
$406M
$90K ﹤0.01%
12,844
-2,697
-17% -$20.2K

Similar funds

ProShare Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, ProShare Advisors held 2,407 positions worth $35.6B, up 4% from $34.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

ProShare Advisors deployed $1.82B of net new capital in Q3 2021, opening 40 new positions and adding to 606 existing holdings. Its largest new stake was Sea Limited: 95,823 shares worth $30.5M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Stamps.com, Inc., an estimated $42.3M trimmed.

  • ProShare Advisors's largest Q3 2021 buy was Sea Limited: 95,823 shares worth $30.5M.
  • ProShare Advisors added most to Apple in Q3 2021, an estimated $172M increase.
  • ProShare Advisors's biggest Q3 2021 reduction was Stamps.com, Inc., cutting an estimated $42.3M.
  • ProShare Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $53.3M.
  • ProShare Advisors's ten largest holdings make up 28% of its $35.6B portfolio in Q3 2021.
  • ProShare Advisors opened 40 new positions and closed 406 in Q3 2021.
  • ProShare Advisors's portfolio value rose 4% quarter-over-quarter to $35.6B.

Based on ProShare Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.